206 related articles for article (PubMed ID: 36476798)
1. [Application of genome editing technology in gene therapy].
Hiramoto T; Ohmori T
Rinsho Ketsueki; 2022; 63(11):1558-1565. PubMed ID: 36476798
[TBL] [Abstract][Full Text] [Related]
2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
3. Molecular Switch Engineering for Precise Genome Editing.
Matsumoto D; Nomura W
Bioconjug Chem; 2021 Apr; 32(4):639-648. PubMed ID: 33825445
[TBL] [Abstract][Full Text] [Related]
4. [Genome editing in plants directed by CRISPR/Cas ribonucleoprotein complexes].
Li X; Shi W; Geng LZ; Xu JP
Yi Chuan; 2020 Jun; 42(6):556-564. PubMed ID: 32694114
[TBL] [Abstract][Full Text] [Related]
5. A glance at genome editing with CRISPR-Cas9 technology.
Barman A; Deb B; Chakraborty S
Curr Genet; 2020 Jun; 66(3):447-462. PubMed ID: 31691023
[TBL] [Abstract][Full Text] [Related]
6. Homology-based repair induced by CRISPR-Cas nucleases in mammalian embryo genome editing.
Zhang X; Li T; Ou J; Huang J; Liang P
Protein Cell; 2022 May; 13(5):316-335. PubMed ID: 33945139
[TBL] [Abstract][Full Text] [Related]
7. Applications of CRISPR/Cas gene-editing technology in yeast and fungi.
Liao B; Chen X; Zhou X; Zhou Y; Shi Y; Ye X; Liao M; Zhou Z; Cheng L; Ren B
Arch Microbiol; 2021 Dec; 204(1):79. PubMed ID: 34954815
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
Li C; Brant E; Budak H; Zhang B
J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas gene therapy.
Zhang B
J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
[TBL] [Abstract][Full Text] [Related]
10. The genome editing revolution: A CRISPR-Cas TALE off-target story.
Stella S; Montoya G
Bioessays; 2016 Jul; 38 Suppl 1():S4-S13. PubMed ID: 27417121
[TBL] [Abstract][Full Text] [Related]
11. Genome Editing: Past, Present, and Future.
Carroll D
Yale J Biol Med; 2017 Dec; 90(4):653-659. PubMed ID: 29259529
[TBL] [Abstract][Full Text] [Related]
12. Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases.
Yu W; Wu Z
Adv Drug Deliv Rev; 2021 Jan; 168():181-195. PubMed ID: 32603815
[TBL] [Abstract][Full Text] [Related]
13. [Genome-editing: focus on the off-target effects].
He X; Gu F
Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1757-1775. PubMed ID: 29082723
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Genome Editing and In Vivo Delivery.
Ramirez-Phillips AC; Liu D
AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
[TBL] [Abstract][Full Text] [Related]
15. [Genome Editing Tools and their Application in Experimental Ophthalmology].
Yanik M; Wende W; Stieger K
Klin Monbl Augenheilkd; 2017 Mar; 234(3):329-334. PubMed ID: 28114701
[TBL] [Abstract][Full Text] [Related]
16. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
17.
Xu M
Cell Biosci; 2020; 10():48. PubMed ID: 32257106
[TBL] [Abstract][Full Text] [Related]
18. Applications of CRISPR/Cas9 technology for modification of the plant genome.
Deb S; Choudhury A; Kharbyngar B; Satyawada RR
Genetica; 2022 Feb; 150(1):1-12. PubMed ID: 35018532
[TBL] [Abstract][Full Text] [Related]
19. [Application progress of CRISPR/Cas9 genome editing technology in the treatment of HIV-1 infection].
Han Y; Li QW
Yi Chuan; 2016 Jan; 38(1):9-16. PubMed ID: 26787519
[TBL] [Abstract][Full Text] [Related]
20. Generating a Genome Editing Nuclease for Targeted Mutagenesis in Human Cells.
He Z; Kee K
Methods Mol Biol; 2017; 1498():153-162. PubMed ID: 27709574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
